Article: Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific Meeting.(Clinical report)

Article: Pharmacology Update: Rifaximin Tablets ...
Internal Medicine Alert;  July 15, 2004 ;     700+ words ... ... be sought..sup.1 Rifaximin is supplied as 200 mg ... Potential Advantages Rifaximin is essentially not absorbed ... excreted in the urine. Adverse events during clinical studies ... similar to placebo and rifaximin has been shown not to ...

Article: Salix Pharmaceuticals Reports Results of Second Phase III Trial ...
Business Wire;  May 29, 2001 ;     700+ words ... ... was: placebo = 60.0, rifaximin 600 mg = 32.5 (p <0.001), and rifaximin 1200 mg = 32.9 (p ... treatment failure. Both rifaximin groups were superior to ... upon the incidence of adverse events (AEs), physical examination ...

Article: Salix's Rifaximin IBS Data Bring Strong Share Bump.
BIOWORLD Today;  October 7, 2008 ;     700+ words ... ... 020). Patients in the rifaximin group also reported significantly ... compared with placebo. Rifaximin was well tolerated in the ... with a similar incidence of adverse events compared with placebo. In ... influenced the response to rifaximin treatment. The co-primary ...

Article: Salix Presents New Phase II Data Evidence Demonstrating the ...
Clinical Trials Week;  October 20, 2008 ;     700+ words ... ... 020). Patients in the rifaximin group also reported significantly ... compared with placebo. Rifaximin was well tolerated in the ... with a similar incidence of adverse events compared with placebo. Severity ... influenced the response to rifaximin treatment (Poster #P1065 ...

Article: Salix Presents New Phase II Data Evidence Demonstrating the ...
Business Wire;  October 6, 2008 ;     700+ words ... ... 020). Patients in the rifaximin group also reported significantly ... compared with placebo. Rifaximin was well tolerated in the ... with a similar incidence of adverse events compared with placebo. Severity ... influenced the response to rifaximin treatment (Poster #P1065 ...

Article: Salix Announces Study Suggesting Rifaximin Potential in ...
Business Wire;  October 13, 2003 ;     700+ words ... ... sixteen week treatment period, Rifaximin reduced the mean Crohn's ... patients, respectively. Rifaximin was well-tolerated. One ... experienced non-serious adverse events considered possibly to be ... with a 200 mg oral dose of Rifaximin three times daily (TID ...

Article: Rifaximin considered as possible treatment for IBS
Formulary;  February 1, 2007 ;     700+ words ... ... patients treated with rifaximin compared with 21.0 ... prevalent adverse event (rifaximin, n=4; placebo, n=3); the frequency of adverse events in general was not statistically ... scores for bloating among rifaximin recipients during follow ...